Ticker Scorecard - CASI Basics Company: CASI Pharmaceuticals, Inc. IPO Date: July 1, 1996 Sector: Healthcare Industry: Biotech Market Cap: $37.96M Activated in VL: True Average Daily Range Avg Daily Range: $0.10 | 3.82% Avg Daily Range (30 D): $0.10 | 3.72% Avg Daily Range (90 D): $0.17 | 4.40% Institutional Daily Volume Avg Daily Volume: .04M Avg Daily Volume (30 D): .01M Avg Daily Volume (90 D): .02M Trade Size Avg Trade Size (Sh.): 42 Avg Trade Size (Sh.) (30 D): 87 Avg Trade Size (Sh.) (90 D): 92 Institutional Trades Total Inst.Trades: 31 Avg Inst. Trade: $1.93M Avg Inst. Trade (30 D): $3.75M Avg Inst. Trade (90 D): $3.75M Avg Inst. Trade Volume: .11M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.69M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 94.73K     News Jun 27, 2024 @ 1:42 PM CASI Pharmaceuticals (CASI) Up on Buyout Offer for... Source: Zacks Equity Research Nov 15, 2023 @ 5:00 PM HC Wainwright & Co. Maintains Buy Rating for CASI ... Source: Benzinga Insights Oct 24, 2023 @ 9:30 PM USANA Health Sciences (USNA) Q3 Earnings Miss Esti... Source: Zacks Equity Research Oct 11, 2023 @ 12:24 PM Why VOXX International Shares Are Trading Higher B... Source: Lisa Levin Aug 10, 2023 @ 2:04 PM Ionis Pharmaceuticals (IONS) Q2 Earnings and Reven... Source: Zacks Equity Research Financials   TTM Q3 2022 Q2 2022 Basic EPS $1.03 $-.38 $-.56 Diluted EPS $1.03 $-.38 $-.56 Revenue $ 37.01M $ 10.21M $ 8.57M Gross Profit $ 21.65M $ 5.97M $ 5.02M Net Income / Loss $ -26.31M $ -5.02M $ -7.49M Operating Income / Loss $ -32.76M $ -6.35M $ -7.75M Cost of Revenue $ 15.36M $ 4.25M $ 3.55M Net Cash Flow $ -13.94M $ 18.97M $ -9.52M PE Ratio 2.38     Splits Jun 02, 2022:   10:1 Jul 01, 2010:   11:1